Analysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $112.00

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given a consensus rating of “Moderate Buy” by the fifteen analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $112.00.

Several equities research analysts have recently issued reports on the company. BMO Capital Markets set a $85.00 price objective on HealthEquity in a report on Tuesday, February 24th. JPMorgan Chase & Co. increased their target price on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. KeyCorp raised their price target on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, January 8th. UBS Group set a $110.00 price target on HealthEquity in a report on Tuesday, February 17th. Finally, Citizens Jmp set a $122.00 price objective on shares of HealthEquity in a report on Thursday, December 4th.

Insider Buying and Selling

In other news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This represents a 19.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently added to or reduced their stakes in the company. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity during the fourth quarter worth about $27,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter valued at about $28,000. True Wealth Design LLC grew its holdings in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after purchasing an additional 317 shares during the period. Finally, Farther Finance Advisors LLC grew its holdings in shares of HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after purchasing an additional 146 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Down 1.9%

Shares of NASDAQ HQY opened at $78.50 on Friday. The firm has a market cap of $6.71 billion, a P/E ratio of 36.01, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity has a 1 year low of $72.76 and a 1 year high of $116.65. The firm’s 50 day moving average price is $82.74 and its 200 day moving average price is $90.63.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.